{"id":"W2559378733","doi":"10.1182/blood.v110.11.1351.1351","title":"Bendamustine Is Safe and Effective in Patients with Rituximab-Refractory, Indolent B-Cell Non-Hodgkin Lymphoma.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Bendamustine; Rituximab; Medicine; Internal medicine; Follicular lymphoma; Refractory (planetary science); Chronic lymphocytic leukemia; Neutropenia; Lymphoma; Oncology; Clinical endpoint; Non-Hodgkin's lymphoma; Salvage therapy; Gastroenterology; Surgery; Chemotherapy; Leukemia; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004110372,0.0002664883,0.0004859512,0.0001413241,0.0001540791,0.0002228808,0.000216581,0.0002851988,0.001560027],"category_scores_gemma":[0.0007199164,0.0001427002,0.0002990747,0.0001537927,0.0001938439,0.0002642585,0.000104552,0.0006088084,0.0002714974],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002502566,"about_ca_system_score_gemma":0.0002468087,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002276479,"about_ca_topic_score_gemma":0.0009060731,"domain_scores_codex":[0.9998639,0.00005952737,0.00001037061,0.00001967223,0.00002846857,0.00001807637],"domain_scores_gemma":[0.9997666,0.00006562878,0.00007420449,0.00001455662,0.0000114093,0.00006748436],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.09648964,0.005520971,0.07118005,0.001009075,0.001397364,0.001946588,0.000269641,0.002091264,0.1100412,0.0002607311,0.006952615,0.7028409],"study_design_scores_gemma":[0.1570804,0.2479592,0.4952437,0.0004666727,0.001748405,0.01261041,0.0001979439,0.005550042,0.03482305,0.0006651783,0.04358841,0.00006652439],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9807969,0.01466389,0.0008000065,0.000528855,0.00006982431,0.0002104837,0.0003370915,0.000132982,0.002460038],"genre_scores_gemma":[0.9962733,0.001843488,0.0005650912,0.0003341729,0.00006314015,0.00006309217,0.0004032383,0.000008343927,0.0004462047],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001560027,"threshold_uncertainty_score":0.005218804,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.003795729831162938,"score_gpt":0.2394623727039284,"score_spread":0.2356666428727655,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}